PRRA Fails to Improve Long-Term Outcomes in Low-Risk Papillary Thyroid Cancer
Postoperative radioiodine remnant ablation did not improve long-term outcomes among patients with low-risk papillary thyroid carcinoma.
American Thyroid Association 2018
US Centers Fail to Analyze Neck Lymph Nodes in Preoperative Ultrasounds for Thyroid Cancer
Most imaging centers in the United States fail to analyze lateral neck lymph nodes during preoperative ultrasounds in patients with thyroid cancer.
BABA Robotic Thyroidectomy Determined to Be Safe and Effective
The BABA robotic thyroidectomy technique appears to be safe, with excellent outcomes in benign and malignant thyroid disease.
First-Line Pembrolizumab Plus Chemoradiotherapy Found to Be Ineffective in Anaplastic Thyroid Cancer
Pembrolizumab plus chemoradiotherapy failed to improve survival and lead to unexpected deaths in a small study of patients with anaplastic thyroid cancer.
Thyroid irAEs Common With PD-L1 Inhibitors
Thyroid-based immune-related adverse events are common among patients treated with PD-L1 inhibitors.
TRK Inhibitor Effective in TRK-Fusion Advanced Thyroid Cancer
The TRK inhibitor larotrectinib was effective and well tolerated among patients with relapsed/refractory advanced TRK-fusion thyroid cancer.
Several Driver Genes, Tumor Suppressors Found to Be Mutated in Anaplastic Thyroid Cancer
Tumor suppressor and driver genes are frequently mutated in Korean patients with anaplastic thyroid cancer.
Want to read more?
Please login or register first to view this content.
Next post in American Thyroid Association 2018
